These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30067788)

  • 21. Subtypes of mild cognitive impairment in patients with Parkinson's disease: evidence from the LANDSCAPE study.
    Kalbe E; Rehberg SP; Heber I; Kronenbuerger M; Schulz JB; Storch A; Linse K; Schneider C; Gräber S; Liepelt-Scarfone I; Berg D; Dams J; Balzer-Geldsetzer M; Hilker R; Oberschmidt C; Witt K; Schmidt N; Mollenhauer B; Trenkwalder C; Spottke A; Roeske S; Wittchen HU; Riedel O; Dodel R
    J Neurol Neurosurg Psychiatry; 2016 Oct; 87(10):1099-105. PubMed ID: 27401782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Which figure copy test is more sensitive for cognitive impairment in Parkinson's disease: Wire cube or interlocking pentagons?
    Alty JE; Cosgrove J; Jamieson S; Smith SL; Possin KL
    Clin Neurol Neurosurg; 2015 Dec; 139():244-6. PubMed ID: 26519897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease.
    Lee JE; Cho KH; Song SK; Kim HJ; Lee HS; Sohn YH; Lee PH
    J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):7-16. PubMed ID: 23828835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beyond PD-MCI: objectively defined subtle cognitive decline predicts future cognitive and functional changes.
    Jones JD; Uribe C; Bunch J; Thomas KR
    J Neurol; 2021 Jan; 268(1):337-345. PubMed ID: 32804281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mild cognitive impairment in Parkinson's disease: Diagnosis and progression to dementia.
    Galtier I; Nieto A; Lorenzo JN; Barroso J
    J Clin Exp Neuropsychol; 2016; 38(1):40-50. PubMed ID: 26602176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal decline of driving safety in Parkinson disease.
    Uc EY; Rizzo M; O'Shea AMJ; Anderson SW; Dawson JD
    Neurology; 2017 Nov; 89(19):1951-1958. PubMed ID: 29021353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive impairment in Parkinson's disease, Alzheimer's dementia, and vascular dementia: the role of the clock-drawing test.
    Allone C; Lo Buono V; Corallo F; Bonanno L; Palmeri R; Di Lorenzo G; Marra A; Bramanti P; Marino S
    Psychogeriatrics; 2018 Mar; 18(2):123-131. PubMed ID: 29417704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Everyday action impairment in Parkinson's disease dementia.
    Giovannetti T; Britnell P; Brennan L; Siderowf A; Grossman M; Libon DJ; Bettcher BM; Rouzard F; Eppig J; Seidel GA
    J Int Neuropsychol Soc; 2012 Sep; 18(5):787-98. PubMed ID: 22621995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progression of subcortical atrophy in mild Parkinson's disease and its impact on cognition.
    Foo H; Mak E; Yong TT; Wen MC; Chander RJ; Au WL; Sitoh YY; Tan LC; Kandiah N
    Eur J Neurol; 2017 Feb; 24(2):341-348. PubMed ID: 27943468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal assessment of the pattern of cognitive decline in non-demented patients with advanced Parkinson's disease.
    Gasca-Salas C; Estanga A; Clavero P; Aguilar-Palacio I; González-Redondo R; Obeso JA; Rodríguez-Oroz MC
    J Parkinsons Dis; 2014; 4(4):677-86. PubMed ID: 25208730
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Symbol-Digit Modalities Test in Mild Cognitive Impairment: Evidence from Parkinson's Disease Patients.
    Pascoe M; Alamri Y; Dalrymple-Alford J; Anderson T; MacAskill M
    Eur Neurol; 2018; 79(3-4):206-210. PubMed ID: 29597229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subjective cognitive decline predicts future deterioration in cognitively normal patients with Parkinson's disease.
    Hong JY; Sunwoo MK; Chung SJ; Ham JH; Lee JE; Sohn YH; Lee PH
    Neurobiol Aging; 2014 Jul; 35(7):1739-43. PubMed ID: 24507441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
    Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
    Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Subtypes of mild cognitive impairment in Parkinson's disease and factors predicting its becoming dementia].
    Toribio-Diaz ME; Carod-Artal FJ
    Rev Neurol; 2015 Jul; 61(1):14-24. PubMed ID: 26108904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosing mild cognitive impairment in Parkinson's disease: which tests perform best in the Italian population?
    Federico A; Trentin M; Zanette G; Mapelli D; Picelli A; Smania N; Tinazzi M; Tamburin S
    Neurol Sci; 2017 Aug; 38(8):1461-1468. PubMed ID: 28550344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal changes in cognition in early Parkinson's disease patients with REM sleep behavior disorder.
    Chahine LM; Xie SX; Simuni T; Tran B; Postuma R; Amara A; Oertel WH; Iranzo A; Scordia C; Fullard M; Linder C; Purri R; Darin A; Rennert L; Videnovic A; Del Riva P; Weintraub D
    Parkinsonism Relat Disord; 2016 Jun; 27():102-6. PubMed ID: 27010070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal brain volumetric changes and their predictive effects on cognition among cognitively asymptomatic patients with Parkinson's disease.
    Wen MC; Ng A; Chander RJ; Au WL; Tan LC; Kandiah N
    Parkinsonism Relat Disord; 2015 May; 21(5):483-8. PubMed ID: 25753847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural course of mild cognitive impairment in Parkinson disease: A 5-year population-based study.
    Pedersen KF; Larsen JP; Tysnes OB; Alves G
    Neurology; 2017 Feb; 88(8):767-774. PubMed ID: 28108638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Parkin'Play study: protocol of a phase II randomized controlled trial to assess the effects of a health game on cognition in Parkinson's disease.
    van de Weijer SC; Duits AA; Bloem BR; Kessels RP; Jansen JF; Köhler S; Tissingh G; Kuijf ML
    BMC Neurol; 2016 Nov; 16(1):209. PubMed ID: 27809791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.